Krebs Biochemicals & Industries Limited (KREBSBIO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 857.45M |
| Enterprise Value | 3.1B |
| P/E Ratio | -9.53 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 4.74 |
| Price/Book Ratio | -0.75 |
| Enterprise/Revenue | 13.18 |
| Enterprise/EBITDA | 1,055.66 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.5 |
| Operating Margin | -0.3 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 237.32M |
| Revenue/Share | 12.46 |
| Gross Profit | 65.3M |
| EBITDA | -34.24M |
| Net Income | -169.33M |
| Diluted EPS | -7.85 |
Balance Sheet
| Total Cash | 1.26M |
| Total Cash/Share | 0.06 |
| Total Debt | 2.27B |
| Total Debt/Equity | -1.33 |
| Current Ratio | 0.06 |
| Book Value Per Share | -79.14 |
Price History
| 52-Week Change | -13.09 |
| 52-Week High | 76.85 |
| 52-Week Low | 38.33 |
| Moving Average 50 Days | 58.12 |
| Moving Average 200 Days | 57.51 |
Statistics
| Average Volume | 27,927 |
| Shares Outstanding | 21.56M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 207:200 |
| Last Split Date | January 31, 2019 |
AD
